AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

July 8, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search